New era of cell-based orthopedic therapies

Tissue Engineering - Part B: Reviews

Volumn 15, Issue 2, 2009, Pages 195-200

  Caplan, Arnold I ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVE FACTOR; BONE FORMATION; BONE MARROW; CELL-BASED; CELL-BASED THERAPY; FUNCTIONAL RELATIONSHIP; MESENCHYMAL STEM CELL; MICROENVIRONMENTS; ORTHOPEDIC SURGERY; OSTEOPROGENITORS; PROGENITOR CELL; REGENERATION DYNAMICS; SKELETAL TISSUES; STANDARD PRACTICES; VASCULATURE;

BLOOD; BONE; CELL CULTURE; CELL MEMBRANES; FLOWCHARTING;

BLOOD VESSELS;

ADULT; BONE MARROW TRANSPLANTATION; CELL THERAPY; CHONDROCYTE IMPLANTATION; HUMAN; IMMUNOMODULATION; MESENCHYMAL STEM CELL; ORTHOPEDICS; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING;

ANIMALS; BONE DISEASES; CHONDROCYTES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; STEM CELL NICHE;

EID: 70349971384     PISSN: 19373368     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.teb.2008.0515     Document Type: Review

References (59)

1. Pechak, D.G., Kujawa, M.J., and Caplan, A.I. Morphological and histological events during first bone formation in embryonic chick limbs. Bone 7, 441, 1986.
2. Pechak, D.G., Kujawa, M.J., and Caplan, A.I. Morphology of bone development and bone remodeling in embryonic chick limbs. Bone 7, 459, 1986.
3. Caplan, A.I., and Pechak, D.G. The cellular and molecular embryology of bone formation. In: Peck, W.A., ed. Bone and Mineral Research. New York: Elsevier, vol.5, 1987, pp. 117-184.
4. Caplan, A.I. Stem cell delivery vehicle. Biomaterials 11, 44, 1990.
5. Caplan, A.I. Mesenchymal stem cells. J Orthop Res 9, 641, 1991.
6. Ohgushi, H., and Caplan, A.I. Stem cell technology and bioceramics: from cell to gene. Eng J Biomed Mater Res 48,1, 1999.
7. Dennis, J.E., Konstantakos, E.K., Arm, D., and Caplan, A.I. In vivo osteogenesis assay: a rapid method for quantitative analysis. Biomaterials 19, 1323, 1998.
8. Caplan, A.I. Mesenchymal stem cell: cell-based reconstructive therapy in orthopaedics. Tissue Eng 11, 1198, 2005.
9. Bruder, S.P., and Caplan, A.I. Bone regeneration through cellular engineering. In: Lanza, R., Langer, R., and Vancanti, J., eds. Principles in Tissue Engineering. New York: Springer, 2000, pp. 683-696.
10. Steadman, J., Briggs, K., Rodrigo, J., Kocher, M., Gill, T., and Rodkey, W. Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy 19, 477, 2003.
11. Mithoefer, K., Williams, R.J., III, Warren, R.F., Potter, H.G., Spock, C.R., Jones, E.C., Wickiewicz, T.L., and Marx, R.G. The microfracture technique for the treatment of articular cartilage lesions in the knee: a prospective cohort study. J Bone Joint Surg Am 87, 1911, 2005.
12. Brittberg, M., Lindahl, A., Nilsson, A., Ohlsson, C, Isaksson, O., and Peterson, L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331, 889, 1994.
13. Peterson, L., Minas, T., Brittberg, M., Nilsson, A., Sjogren-Jansson, E., and Lindahl, A. Two-to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop 374, 212, 2000.
14. Pavesio, A., Abatangelo, G., Borrione, A., Brocchetta, D., Hollander, A.P., Kon, E., Torasso, F., Zanaasi, S., and Marcacci, M. Hyaluronan-based scaffolds (Hyalograft® C) in the treatment of knee cartilage defects: preliminary clinical findings. In: Wiley, Chichester, eds. Tissue Engineering of Cartilage and Bone. Novartis Foundation Symposium, 2003, pp. 203-217.
15. Dell'Accio, F., De Bari, C, and Luyten, F.P. Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum 44, 1608, 2001.
16. Dell'Accio, F., Vanlauwe, J., Bellemans, J., Neys, J., DeBari, C, and Luyten, F.P. Expanded phenotypically stable chondrocytes persist in the repair tissue and contribute to cartilage matrix formation and structural integration in a goat model of autologous chondrocyte implantation. J Orthop Res 21, 123, 2003.
17. Liebergall, M., Young, R.G., Ozawa, N., Reese, J.H., Davy, D.T., Goldberg, V.M., and Caplan, A.I. The effects of cellular manipulation and TGF-ß in a composite graft. In: Brighton, C.T., Friedlaender, G.E., and Lane, J.M., eds. Bone Formation and Repair. American Academy of Orthopaedic Surgeons Symposium, Tampa, Florida, 1994, pp. 367-378.
18. Wakitani, S., Goto, T., Pineda, S.J., Young, R.G., Mansour, J.M., Goldberg, V.M., and Caplan, A.I. Mesenchymal cell-based repair of large full-thickness defects of articular cartilage and underlying bone. J Bone Joint Surg 76, 579, 1994.
19. Saito, T., Dennis, J.E., Lennon, D.P., Young, R.G., and Caplan, A.I. Myogenic expression of mesenchymal stem cells within myotubes of mdx mice in vitro and in vivo. Tissue Eng 1, 327, 1996.
20. Young, R.G., Butler, D.L., Weber, W., Gordon, S.L., Fink, D.J., and Caplan, A.I. The use of mesenchymal stem cells in Achilles tendon repair. J Orthop Res 16, 406, 1998.
21. da Silva Meirelles, L., Caplan, A.I., and Nardi, N.B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26, 2287, 2008.
22. Haynesworth, S.E., Baber, M.A., and Caplan, A.I. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13, 69, 1992.
23. Barry, F.P., Boynton, R.E., Haynesworth, S., Murphy, J.M., and Zaia, J. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope of endoglin (CD105). Biochem Biophys Res Commun 265, 134, 1999.
24. Barry, F., Boynton, R., Murphy, M., and Zaia, J. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun 28, 519, 2001.
25. Johnstone, B., Hering, T.M., Goldberg, V.M., Yoo, J.U., and Caplan, A.I. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238, 265, 1998.
26. Yoo, J.U., Barthel, T.S., Nishimura, K., Solchaga, L.A., Caplan, A.I., Goldberg, V.M., and Johnstone, B. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg 80, 1745, 1998.
27. Estes, B.T., Wu, A.W., and Guilak, F. Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthritis Rheum 54, 1222, 2006.
28. Haynesworth, S.E., Baber, M.A., and Caplan, A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1a. J Cell Physiol 166, 585, 1996.
29. Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, G., Bernardo, M.E., Rem-berger, M., Dini, G., Egeler, R.M., Bacigalupo, A., Fibbe, W., and Ringden, O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371, 1579, 2008.
30. Li, Y., Chen, J., Chen, X.G., Wang, L., Gautam, S.C., Xu, Y.X., Katakowski, M., Zhang, L.J., Lu, M., Janakirman, N., and Chop, M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59, 514, 2002.
31. Mahmood, A., Lu, D., and Chopp, M. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 53, 697, 2003.
32. Bai, L., Lennon, D.P., Eaton, V., Maier, K., Caplan, A.I., Miller, S.D., and Miller, R.H. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. GLIA, Epub ahead of print 2009.
33. Caplan, A.I., and Dennis, J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 98, 1076, 2006.
34. Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., and Ringden, O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31, 890, 2003.
35. Bacigalupo, A., Valle, M., Podesta, M., Pitto, A., Zocchi, E., DeFlora, A., Possi, S., Vassallo, F., Lucchetti, S., Figari, O., Frassoni, F., and Piaggio, G. The suppressive effect of bone marrow mesenchymal stem cells on T cell activation is deficient in patients with severe aplastic anemia. Blood 104, 147A, 2004.
36. Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan, H., Galun, E., and Rachmielwitz, J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T cell unresponsiveness. Blood 105, 2214, 2005.
37. Le Blanc, K., Rasmusson, I., Gotherstrom, C., Seidel, C., Sundberg, B., Sundin, M., Rosendahl, K., Tammik, C., and Ringden, O. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglu-tinin-activated lymphocytes. Scand J Immunol 60, 307, 2004.
38. Majumdar, M.K., Thiede, M.A., Mosca, J.D., Moorman, M., and Gerson, S.L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176, 186, 1998.
39. Lazarus, H.M., Haynesworth, S.E., Gerson, S.L., Rosenthal, N., and Caplan, A.I. Ex-vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells) [MPCs]: implications for therapeutic use. Bone Marrow Transplant 16, 557, 1995.
40. Koc, O.N., Day, J., Nieder, M., Gerson, S.L., Lazarus, H.M., and Krivit, W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30, 215, 2002.
41. Koc, O.N., Gerson, S.L., Cooper, B.W., Dyhouse, S.M., Haynesworth, S.E., Caplan, A.I., and Lazarus, H.M. Rapid hematopoietic recovery after confusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18, 307, 2000.
42. Horwitz, E.M., Gordon, P.L., Koo, W.K.K., Marx, J.C., Neel, M.D., McNall, R.Y., Muul, L., and Hoffman, T. Isolated al-logeneic bone marrow derived mesenchymal ells engraft and stimulate growth in children with osteogenesis im-perfeta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99, 8932, 2002.
43. Pittenger, M., Mackay, A., Beck, S., Jaiswal, R., Douglas, R., Mosca, J., Moorman, M., Simonetti, D., Craig, S., and Mar-shak, D. Multilineage potential of adult human mesenchy-mal stem cells. Science 284, 143, 1999.
44. Aggarwal, S., and Pittenger, M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815, 2005.
45. Pittenger, M.F., and Martin, B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95, 9, 2004.
46. Hofstetter, C.P., Schwarz, E.J., Hess, D., Widenfalk, J., El Manira, A., Prockop, D.J., and Olson, L. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 99, 2199, 2002.
47. Lange, C., Togel, F., Ittrich, H., Clayton, F., Nolte-Ernsting, C., Zander, A.R., and Westenfelder, C. Administered mesenchy-mal stem cells enhance recovery from ischemia=reperfusion-induced acute renal failure in rats. Kidney Int 68, 1613, 2005.
48. Murphy, J.M., Fink, D.J., Hunziker, E.B., and Barry, F.P. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48, 3464, 2003.
49. da Silva Meirelles, L., Caplan, A.I., and Nardi, N.B. The mesenchymal stem cell niche. Stem Cells 26, 2287, 2008.
50. Singer, M. The trophic quality of the neuron: some theoretical considerations. In: Singer, M., Schade, J.P., eds. Progress in Brain Research. Amsterdam, The Netherlands: Elsevier, vol 13, 1964, pp. 228-232.
51. Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Pier-santi, S., Saggio, I., Tagliafico, E., Ferrari, S., Robey, P.G., Riminucci, M., and Bianco, P. Self-renewing osteoprogeni-tors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324, 2007.
52. Crisan, M., Deasy, B., Gavina, M., Zheng, B., Huard, J., Lazzaari, L., and Peault, B. Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol 86, 295, 2008.
53. Hirschi, K., and D'Amore, P.A. Pericytes in the microvas-culature. Cardiovasc Res 32, 687, 1969.
54. Brighton, C.T., Lorich, D.G., Kupcha, R., Reilly, T.M., Jones, A.R., and Woodbury, R.A. The pericyte as a possible oste-oblast progenitor cell. Clin Orthop Relat Res 275, 287, 1992.
55. Crisan, M., Yap, S., Casteilla, L., Chen, C., Corselli, M., Park, T.S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., Norotte, C., Teng, P.N., Traas, J., Schugar, R., Deasy, B.M., Badylak, S., Bü hring, H.J., Giacobino, J.P., Lazzari, L., Huard, J., and Péault, B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301, 2008.
56. Sorrell, J.M., Baber, M.A., and Caplan, A.I. Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A, Volume 15, 2009.
57. Le Blanc, K., Tammit, L.L., Sundberg, B., Haynesworth, S.E., and Ringden, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57, 11, 2003.
58. Maitra, B., Szekely, E., Gjini, K., Laughlin, M.J., Dennis, J., Haynesworth, S.E., and Koc, O.N. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33, 597, 2004.
59. Penn. M.S., and Khalil, M.K. Exploitation of stem cell homing for gene delivery. Expert Opin Biol Ther 8, 17, 2008.